Search Page

1

Cite

Share

Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.

Garg SK, Strumph P. Garg SK, et al. Among authors: strumph p. N Engl J Med. 2018 Mar 8;378(10):967-968. doi: 10.1056/NEJMc1800394. N Engl J Med. 2018. PMID: 29514037 No abstract available.

Cite

Share

2

Cite

Share

Healthcare transition from pediatric to adult medical homes in diabetes mellitus.

Turner JR, Schatz DA, Cusi K, Strumph P. Turner JR, et al. Among authors: strumph p. Endocr Pract. 2014 Jul;20(7):715-21. doi: 10.4158/EP13369.RA. Endocr Pract. 2014. PMID: 24449671

Cite

Share

3

Cite

Share

LX4211 therapy reduces postprandial glucose levels in patients with type 2 diabetes mellitus and renal impairment despite low urinary glucose excretion.

Zambrowicz B, Lapuerta P, Strumph P, Banks P, Wilson A, Ogbaa I, Sands A, Powell D. Zambrowicz B, et al. Among authors: strumph p. Clin Ther. 2015 Jan 1;37(1):71-82.e12. doi: 10.1016/j.clinthera.2014.10.026. Epub 2014 Dec 17. Clin Ther. 2015. PMID: 25529979 Clinical Trial.

Cite

Share

4

Cite

Share

Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.

Lapuerta P, Zambrowicz B, Strumph P, Sands A. Lapuerta P, et al. Among authors: strumph p. Diab Vasc Dis Res. 2015 Mar;12(2):101-10. doi: 10.1177/1479164114563304. Diab Vasc Dis Res. 2015. PMID: 25690134 Review.

Cite

Share

5

Cite

Share

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.

Sands AT, Zambrowicz BP, Rosenstock J, Lapuerta P, Bode BW, Garg SK, Buse JB, Banks P, Heptulla R, Rendell M, Cefalu WT, Strumph P. Sands AT, et al. Among authors: strumph p. Diabetes Care. 2015 Jul;38(7):1181-8. doi: 10.2337/dc14-2806. Epub 2015 Jun 6. Diabetes Care. 2015. PMID: 26049551 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.

Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D, Lapuerta P, Simó R, Danne T, McGuire DK, Kushner JA, Peters A, Strumph P. Garg SK, et al. Among authors: strumph p. N Engl J Med. 2017 Dec 14;377(24):2337-2348. doi: 10.1056/NEJMoa1708337. Epub 2017 Sep 13. N Engl J Med. 2017. PMID: 28899222 Free article. Clinical Trial.

Cite

Share

7

Cite

Share

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.

Buse JB, Garg SK, Rosenstock J, Bailey TS, Banks P, Bode BW, Danne T, Kushner JA, Lane WS, Lapuerta P, McGuire DK, Peters AL, Reed J, Sawhney S, Strumph P. Buse JB, et al. Among authors: strumph p. Diabetes Care. 2018 Sep;41(9):1970-1980. doi: 10.2337/dc18-0343. Epub 2018 Jun 24. Diabetes Care. 2018. PMID: 29937430 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

HbA_1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.

Danne T, Cariou B, Banks P, Brandle M, Brath H, Franek E, Kushner JA, Lapuerta P, McGuire DK, Peters AL, Sawhney S, Strumph P. Danne T, et al. Among authors: strumph p. Diabetes Care. 2018 Sep;41(9):1981-1990. doi: 10.2337/dc18-0342. Epub 2018 Jun 24. Diabetes Care. 2018. PMID: 29937431 Clinical Trial.

Cite

Share

9

Cite

Share

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.

Danne T, Cariou B, Buse JB, Garg SK, Rosenstock J, Banks P, Kushner JA, McGuire DK, Peters AL, Sawhney S, Strumph P. Danne T, et al. Among authors: strumph p. Diabetes Care. 2019 May;42(5):919-930. doi: 10.2337/dc18-2149. Epub 2019 Mar 4. Diabetes Care. 2019. PMID: 30833371 Free PMC article.

Cite

Share

10

Cite

Share

Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.

Baker C, Wason S, Banks P, Sawhney S, Chang A, Danne T, Gesty-Palmer D, Kushner JA, McGuire DK, Mikell F, O'Neill M, Peters AL, Strumph P. Baker C, et al. Among authors: strumph p. Diabetes Obes Metab. 2019 Nov;21(11):2440-2449. doi: 10.1111/dom.13825. Epub 2019 Aug 1. Diabetes Obes Metab. 2019. PMID: 31264767 Free PMC article. Clinical Trial.

Cite

Share